医药流通领域商业贿赂的经济伦理思考  

Economic Ethics Consideration on Commercial Bribery in Pharmaceutical Circulation Field

作　　者：王海星[1] 侯胜田[1] 

机构地区：[1]北京中医药大学管理学院,北京100029

出　　处：《中国药业》2015年第2期1-3,共3页China Pharmaceuticals

基　　金：2012年度教育部人文社会科学研究规划基金资助项目;项目编号:12YJAZH031;北京市中医药文化研究基地资助项目;北京市共建项目资助项目

摘　　要：医药流通领域商业贿赂行为是企业漠视商业伦理和社会责任缺失的表现,反映出当前市场经济秩序存在深层次问题,亟待通过改革加以调整。该文从经济伦理角度分析了医药流通领域商业贿赂行为的成因,认为企业内部疏于管控、管理层社会责任意识淡薄是导致商业贿赂的直接原因,"以药养医"卫生体制是造成医药流通领域商业贿赂盛行的根源。建立和维护公正的市场经济秩序需要各方共同努力,企业要强化商业伦理和社会责任意识,规范经营行为;监管部门要依法强化监管,严惩违规行为;行业协会要建立行业伦理和社会责任标准,引导企业自律。The commercial bribery behavior in the pharmaceutical circulation field is the manifestation of enterprises for neglecting the business ethics and social responsibility and reflects the deep-seated problems existing in the current market economy order,which ur- gently demands to be rectified through reform. This paper analyzes the causes of commercial bribery from the perspective of business ethics. It is considered that neglecting the internal control and the weak awareness of corporation social responsibility（CSR） are the di- rect causes leading to the commercial bribery, and the health system of drug- maintaining- medicine is the root source giving rise to the commercial bribery prevailing. The establishment and maintenance of fair market economy order require the joint efforts of relevant parties, enterprises should strengthen the awareness of business ethics and CSR and standardize the business behaviors; the supervision departments should severely punish the illegal behaviors;the industrial associations should establish the industrial ethical and social responsibility standards,and guide the enterprise self- discipline.

关 键 词：医药流通领域 商业贿赂 经济伦理 企业社会责任 

分 类 号：F715[经济管理—产业经济] F763